Vai al contenuto principale della pagina

The Public Health Emergency Medical Countermeasures Enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / / Theresa Wizemann, Clare Stroud and Bruce M. Altevogt ; Forum on Medical and Public Health Preparedness for Catastrophic Events, Forum on Drug Discovery, Development and Translation, Board on Health Sciences Policy



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: The Public Health Emergency Medical Countermeasures Enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / / Theresa Wizemann, Clare Stroud and Bruce M. Altevogt ; Forum on Medical and Public Health Preparedness for Catastrophic Events, Forum on Drug Discovery, Development and Translation, Board on Health Sciences Policy Visualizza cluster
Pubblicazione: Washington, D.C., : National Academies Press, 2010
Edizione: 1st ed.
Descrizione fisica: 1 online resource (194 p.)
Disciplina: 362.1
Soggetto topico: Emergency medicine
Altri autori: WizemannTheresa M  
StroudClare  
AltevogtBruce M  
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references.
Nota di contenuto: ""Front Matter""; ""Reviewers""; ""Contents""; ""INTRODUCTION""; ""BACKGROUND""; ""PARTNERS IN A SINGLE MISSION, DIVERSE CONCERNS AND CHALLENGES""; ""EXAMPLES OF SUCCESSFUL COUNTERMEASURES DEVELOPMENT AND DEPLOYMENT""; ""PARTNERSHIPS AND ALTERNATIVE BUSINESS MODELS""; ""ENGAGING INDUSTRY""; ""NEW PARADIGMS, STRATEGIES, AND TACTICS FOR ENHANCING THE COUNTERMEASURES DEVELOPMENT ENTERPRISE""; ""EXISTING REGULATORY TOOLS AND APPROACHES THAT CAN BE APPLIED TO ADVANCE COUNTERMEASURES DEVELOPMENT""; ""CONCLUSION""; ""Appendix A: References""; ""Appendix B: Workshop Agenda""
""Appendix C: Registered Workshop Attendees""""Appendix D: Case Studies of HHS Chemical, Biological, Radiological, and Nuclear Medical Countermeasure Development Programs, Executive Summary""; ""Appendix E: Synthesis of Business Models and Economic and Market Incentives for Vaccines and Therapeutics""
Sommario/riassunto: "During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE--a partnership among federal, state, and local governments; industry; and academia) is at the forefront of the effort to develop and manufacture these countermeasures. However, despite the PHEMCE's many successes, there are still serious challenges to overcome. Government-funded medical research is not always focused on countermeasures for the most serious potential threats, and it is difficult to engage pharmaceutical and biotechnology companies to develop and manufacture medical countermeasures that have a limited commercial market. At the request of the Secretary of the U.S. Department of Health and Human Services and the Assistant Secretary for Preparedness and Response, the IOM held a workshop February 22-24, 2010, to address challenges facing the PHEMCE. Workshop participants discussed federal policies and procedures affecting the research, development, and approval of medical countermeasures and explored opportunities to improve the process and protect Americans' safety and health"--National Academies Press description.
Titolo autorizzato: The Public Health Emergency Medical Countermeasures Enterprise  Visualizza cluster
ISBN: 9786612644870
9780309156486
0309156483
9781282644878
1282644874
9780309150255
0309150256
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910966870103321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui